Already in September last year, Der Spiegel published an interview with Peter Wilmshurst, a British medical doctor and whistleblower who made fraudulent practices in medical research public:
In the course of the 66-year-old’s career, he conducted studies for pharmaceutical and medical devices companies, and unlike many of his colleagues, never hesitated to publish negative results. He’s been the subject of multiple cases of legal action and risked bankruptcy and his reputation to expose misconduct in the pharmaceutical industry.
A very interesting article that’s worth reading. Fact is, that companies who have a strong economic interest in the scientific process will have an impact on the quality of the research. It is, again and again, horrible to learn how far companies try to go – and often successfully do. While medical companies has always been an obvious target (and perpetrator), the problem runs deeper than the narrative of “Big Pharma”.